Navigation Links
Lilly and MacroGenics Announce Licensing and Collaboration Agreement
Date:10/18/2007

ations for teplizumab or other next generation anti-CD3 molecules developed with MacroGenics. If Lilly pursues each one of those indications and they all ultimately gain approval, additional milestone payments to MacroGenics could exceed $600 million. Other terms of the deal were not disclosed.

The transaction is expected to become effective in the fourth quarter of 2007, contingent upon clearance under the Hart-Scott-Rodino Anti-Trust Improvements Act, if required. At closing, Lilly would expect a charge to earnings for acquired in-process research and development. The amount of the charge has not yet been determined, but is estimated to be $0.03 per share. The impact to Lilly's fourth quarter and full-year 2007 earnings per share guidance is included in the 2007 Financial Guidance section of Lilly's third quarter financial results press release that was issued today.

"This agreement will expand Lilly's pipeline of late stage molecules and will strengthen one of our core therapeutic areas," said David Moller, M.D., Lilly, vice president of endocrine and cardiovascular research and clinical investigation. "We remain committed to maintaining our leadership role in diabetes care, including an expanded presence in the area of type 1 diabetes. We will continue to seek out innovative molecules to add to our diabetes portfolio in order to best respond to the growing health crisis posed by diabetes worldwide."

"Teplizumab is a significant addition to our growing portfolio of biotechnology-derived medicines, which are a key strategy for Lilly," said Thomas Bumol, Ph.D., Lilly, vice president, biotechnology discovery research, and president, Applied Molecular Evolution. "Immune tolerance represents a novel therapeutic approach to the treatment of autoimmune disease, and we are excited to be partnering with MacroGenics to clinically evaluate this mechanism in type 1 diabetes."

"We are delighted to enter into this deal with Lilly, an established leader
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Animal insulin product to be discontinued by drug major Eli Lilly
2. Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?
3. Eli Lilly Releases Digital Insulin Pen
4. OHSU Researchers Announce New Discovery
5. PM announces a new health care order for India
6. Partnership Between Diabetes India And Elsevier Announced
7. US Politicians Urge Movie Moghuls To Add Anti-Smoking Announcements
8. Ramdoss Announces Introduction of RCH-II
9. Britain Announces Third Transfusion Related Mad Cow Case
10. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
11. Tibet Announces the Dalai Lama’s Tour of South Americ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 31, 2014 Fast hosting is ... Top10BestSEOHosting.com has recently compared many professional web hosting ... ) and Arvixe are the suppliers of fastest ... to find a good fast hosting supplier. Actually, ... features, uptime, server speed and customer support. People ...
(Date:8/30/2014)... August 30, 2014 Information supplied by ... to introduce better prices to consumers in 2014. A ... be found when using the open system for adults ... system available to use this year can help the ... on general location and not from medical histories. The ...
(Date:8/30/2014)... Daily Gossip reveals in its review a program created by ... shows a unique formula to get inside a man’s mind ... the program goes beyond mere attraction and actually helps ladies ... that the program was created by dating expert Alex Carter, ... make a man feel emotionally addicted. , Learn more about ...
(Date:8/30/2014)... New York (PRWEB) August 30, 2014 ... combination of Nutrition and Pharameuticals. Nutraceuticals is a ... extracting healthy ingredients from natural food sources. Nutraceutical ... health benefits to the human body. Nutraceutical health ... diet supplements, fortified foods and more. Although nature ...
(Date:8/30/2014)... After offering hyperbaric oxygen therapy treatments ... several years, Dr. Roy Schmidt and the staff ... scholarship program for veterans who have been diagnosed ... this summer to discuss veterans’ needs ( http://www.prweb.com/releases/2014/06/prweb11954058.htm ... light on the large number of veterans who ...
Breaking Medicine News(10 mins):Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2
... Houston - The University of Texas MD Anderson Cancer Center ... Academy of Sciences (NAS) - one of the most prestigious ... science and engineering. DePinho is the first member of ... The NAS is a private, nonprofit society of ...
... Cone beam CT is superior to mutidetector CT for detecting superior ... hole in the bony wall of the inner ear bone that ... radiation dose, a new study shows. , The study, conducted in ... CT and a multidetector CT examination of their right and left ...
... Over the past decade, there has been a steady ... oil capsules. According to Dr. Louise Moist, a Scientist ... improve outcomes for kidney patients undergoing hemodialysis. ... vessels created to join an artery to a vein. ...
... School of Medicine have gained insight into the mechanism ... to the progression of Alzheimer,s disease (AD) and other ... issue of the Journal of Biological Chemistry, ... to prevent tau from damaging brain circuits involved in ...
... May 1 (HealthDay News) -- A combination of moderate exercise ... risk of age-related memory loss more than computer use or ... in the May issue of Mayo Clinic Proceedings , ... 70 to 93, who completed questionnaires about their computer use ...
... the signaling pathways active in sarcomas, researchers at Moffitt ... a family of protein enzymes that act as "on" ... The tyrosine kinases they identified, the researchers said, could ... sarcomas. Sarcomas are relatively rare forms of cancer. ...
Cached Medicine News:Health News:UT MD Anderson President Ronald DePinho elected to National Academy of Sciences 2Health News:Everyday fish oil capsule may provide kidney-related benefits 2Health News:Researchers gain better understanding of mechanism behind tau spreading in the brain 2Health News:Exercise Plus Computer Time May Boost Seniors' Brains 2Health News:Moffitt Cancer Center researchers identify drivers of sarcoma growth and survival 2
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
(Date:8/29/2014)... , Aug. 29, 2014  Pacific Medical Data Solutions ... new website design . The main website, along with ... the company,s new services and content relevant to the ... new streamlined design, viewers can now better understand how ... care practices and create a more visible platform about ...
(Date:8/29/2014)... 29, 2014 , Industry ... the inaugural Tweetchat taking place in real-time at ... organised by UBM Live , announces the ... a first of its kind global industry-wide Tweetchat ... supply chain, aimed to stimulate conversations on key ...
Breaking Medicine Technology:ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3PMDS Announces New Website 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
... 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP ... and biotechnology research and development outsourcing company, today announced ... shareholders held in Hong Kong today. ... proposed by the Company: 1. THAT ...
... Masimo (NASDAQ: MASI ) announced today that ... October 1, 2011, after the market closes on October 25, 2011. ... p.m. PT (4:30 p.m. ET) and will be hosted by Joe ... Executive Vice President and Chief Financial Officer. A live ...
Cached Medicine Technology:ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 3
Ruschelit® PVC. Magill tip-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Endotracheal Tube - Soft red rubber. Silkolatex™ coated. Silkolatex™ cuff. Magill tip - oral. Graduated. X-ray opaque....
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. X-ray opaque line. Graduated. Single use. St...
Medicine Products: